Intra-Cellular Therapies to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq:ITCI) announced that CEO Sharon Mates, Ph.D., will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 9:10 AM ET. The conference will be accessible via a live and archived webcast on the company's website, requiring registration 5-10 minutes prior to the event.

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders, leveraging Nobel prize-winning research to create innovative treatments for complex psychiatric and neurologic diseases.

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 9:10 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

CONTACT:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
John Grimaldi
jgrimaldi@burnsmc.com
212-213-0006

Source: Intra-Cellular Therapies Inc.

FAQ

When is Sharon Mates presenting at the J.P. Morgan Healthcare Conference for ITCI?

Sharon Mates, CEO of Intra-Cellular Therapies, will present on January 12, 2021, at 9:10 AM ET.

How can I access the J.P. Morgan Healthcare Conference presentation for ITCI?

The presentation can be accessed via a live and archived webcast on Intra-Cellular Therapies' website under 'Events & Presentations'.

What is the focus of Intra-Cellular Therapies as a company?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

What innovative approach does Intra-Cellular Therapies utilize for its treatments?

The company utilizes an intracellular approach based on Nobel prize-winning research.

Who should I contact for more information about Intra-Cellular Therapies?

Contact Dr. Juan Sanchez, VP of Corporate Communications, at 646-440-9333.